$ADXS news Archives - Top News Guide

Advaxis Inc (OTCMKTS:ADXS) Stock On Radar After Q3 Earnings

September 13, 2022

Clinical stage biotech company Advaxis Inc (OTCMKTS:ADXS) could be one of the companies that could be in focus among investors today after it announced its financial results for the third quarter that ended on July 31, 2022 yesterday. Trading Data On Monday, ADXS stock increased 0.33% to $3.0600 with 1.06K shares, compared to its average volume 4.26K shares. The stock moved within a range of $3.0600 – 3.4700 after opening…

Advaxis Inc (OTCMKTS:ADXS) Announces 1-for-80 Reverse Stock Split: Stock Falls

June 6, 2022

Clinical stage biotech firm Advaxis Inc (OTCMKTS:ADXS) had a fairly tough time in the markets this past Friday as its stock went into a downward spiral and ended up with a decline of as much as 18% for the day. Trading Data On Friday, ADXS stock fell 14% to $0.0620 with more than 1.30 million shares, compared to its average volume of 483K shares. The stock moved within a range…

Advaxis Inc (OTCMKTS:ADXS) To take part at the ASCO Annual Meeting

April 28, 2022

Despite making a major announcement on Wednesday, the Advaxis Inc (OTCMKTS:ADXS) stock was in a downward spiral and ended the day with a decline of as much as 7%. In this situation, it may be a good idea for investors to take a look at the announcement from the biotech company and then figure out if the stock is going to recover or not. Trading Data On Wednesday, ADXS stock…

Herborium Group (OTCMKTS: HBRM) Financials Trend Up Signaling Major Catalysts

Herborium Group, Inc. (OTCMKTS: HBRM) is uniquely positioned at the nexus of two rapidly growing multi-billion dollar markets (1. Natural Skin Care, 2. Acne Treatment and other skin health concerns)HBRM’s Revenue and Earnings continue to trend up HBRM’s cash flow is higher than ever, positioning the company for significant growth in 2022. Herborium Group is a Natural Botanical Therapeutics® Company Maintaining Pharmaceutical Standards and Efficacy HBRM offers a unique combination of products and content in the natural skincare sector. Presently focused on acne treatment and prevention the company tests its natural formulations with the same standards found in the pharmaceutical industry creating higher efficacy, proven safety, and consumer satisfaction. The company is now set to roll out an AI technology platform that will allow its consumers to diagnose the products they need utilizing the company’s proprietary skin diagnostic software. HBRM’s SKIN-NATURA is a curated platform providing integrated, natural, safe, and efficacious products and treatment regimens. This is complemented by support content and personalized know-how focused on skin health and beauty (in the field of dermatology, nutrition, and cosmetology). The platform is driven by AI-based technology to streamline both the diagnostic and deliverables. This allows for seamless integration of the most desirable products and content provided by the company and the NATURA Consortium. Consumers benefit from a comprehensive solution to their needs, delivered in an expedient and user-friendly manner, and at the optimal price point. Herborium will realize multiple revenue streams and brand-building benefits from this program. Consortium partners benefit from cooperative marketing power, innovative technology to interact with consumers, and the Skin Natura brand and expertise. Many companies claim they have natural products for skin problems. The issue is the ‘natural’ buzzword is being used without accountability for efficacy or quality. This is where HBRM shines, the company is a legacy ‘natural’ care company with high-quality efficacy and safety standards, for its own Botanical Therapeutics the Company uses clinical validation and a proactive regulatory strategy based on the FDA’s Botanical Drug Development Guidance for Industry, 2016 to establish and maintain a differential market advantage. Herborium harvests its proprietary therapeutic candidates from Traditional Chinese Medicine with initial confirmatory data and utilizes Western regulatory, clinical, and marketing strategies to successfully introduce the products to the Western markets. This strategy serves to mitigate risk in product development and fortifies marketing strategies. Herborium’s AcnEase product comes with a number of benefits for acne users including: Affordable, effective treatment for acute and chronic acne.Treatment that is safe, all-natural (botanical), and can be used on a longer-term basis.Suitable for females and males; contains no phytoestrogens or other hormone-altering ingredients.Prevents acne scar formation.Provides pain relief for cystic acne and eliminates the need for surgery or steroid injections.Convenient vitamin-like small tablets suitable for all ages, skin tones, and severity of acne.Relief for rosacea-related facial flushing due to dilated blood vessels.Eliminates skin sensitivity and outbreaks due to rosacea Alleviates eye irritation and gastric reflux symptoms secondary to rosacea. HBRM’s Market Opportunity 75% of all people will develop acne, and about 90% of people have some form of skincare concerns, Herborium Group, Inc. (OTCMKTS: HBRM) is uniquely positioned at the nexus of two rapidly growing multi-billion dollar markets 1. Natural Skin Care – The global natural skin care products market size was valued at USD 6.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2022 to 2030. (Grand View Research) 2. Acne Treatment – The global acne treatment market is projected to grow from $9.36 billion in 2022 to $12.97 billion by 2029, exhibiting a CAGR of 4.8% during the forecast period. (Fortune Business Insights) Over 60 million people in the U.S. have acne, and contrary to popular belief, it’s not a condition that only affects teenagers. In fact, the average age of people suffering from acne is 26.5, which is five years older than the average age was just a decade ago. The European acne market is estimated to represent over 120 million individuals, and the Asian and Latin American markets are estimated to be 5 to 7 times larger. In addition, due to a number of factors such as pollution, diet, lifestyle and even genetics, acne is often a chronic disease. The company has gained market share steadily over the past 4 years, and with the launch of its new AI technology could see accelerated growth in 2022. Potential Catalysts for HBRM HBRM announced its highest positive cash flow number ever at the end of fiscal 2021 ($110k). It has used this cash flow to accelerate development and it appears to be paying off.Catalyst #1: Launch of AI TechnologyHBRM’s AI-based platform for integrated product, content, and expertise in the area of skincare SKIN-NATURA® is expected in the 4th Quarter of 2022. Catalyst #2: Q3 FinancialsHBRM’s financial results have been trending up for years. With Q3 closing at the end of August, any guidance on these numbers could send the stock upward.There are several other potential catalysts that we may not be aware of, but the above two are near certainties that would have a positive effect on the stock. Make sure to start your research on HBRM today! This article is part of a sponsored investor education program
Read more
WHSI Positioned to Earn Market Share in Telehealth as TDOC Tumbles

WHSI’s new 4G device is anticipated to launch in late-AugustWHSI has announced its device will serve the virtual care/ telehealth marketTelehealth is seen growing by 32.1% annually over the next 6 years According to Fortune Business Insights, the global telehealth market size is anticipated to reach $636.38 billion by 2028 and exhibit a CAGR of 32.1% during the forecast period. The ubiquity of smartphones and the paradigm-changing pandemic have made telehealth and virtual care the ‘new normal.’ Recognizing this, Wearable Health Solutions, Inc. (OTCMKTS: WHSI) has announced with its 4G release in late August, the company expects to launch an entire expanded ecosystem of products to its dealer and vendor networks with a Remote Patient Monitoring (RPM) vertical initiative that will integrate existing monitoring hardware and software solutions into a complete ecosystem to streamline and simplify care of chronically ill patients. Investors have done well in the telehealth market recently. Teladoc Health (NYSE: TDOC) is up 25% in the last 30 days, DexCom, Inc. (Nasdaq: DXCM) is up 14% over the same period. Many of the other leaders in the space are private but have seen venture capital come in bunches. WHSI will now attract investors in the space with a taste for speculation. The company is set to launch a brand new device that could dramatically expand its already healthy customer base of 8,000 end users plus an order book of about 2,000+ potential activations. “We have engaged industry marketing experts and working with advisors specifically to help deploy the RPM and Chronic Care Management solutions to be implemented by physicians groups, healthcare systems, HMOs, Pharmaceutical companies, and to be user-friendly for patients on a daily basis, stated Peter Pizzino President, “the company expects to increase its revenues and profitability as a result of the RPM product offering”. Teladoc investors may be in profit-taking mode after yesterday’s disappointing Q2 numbers and FY guidance. The company lost $3 billion and cited concerns that smaller competitors are taking market share from its “Better Health” product. WHSI will be one of those competitors with its 4G iHelp Max. The telehealth market is expanding rapidly, however, with any fast-growing new market it is still shaking out. First movers like Teladoc and DexCom were able to secure a large share of public investment, but as reflected in TDOC’s latest financials it is struggling to translate that capital into market share. WHSI, is an earlier stage and gives investors more near-term upside from its current share price. Telehealth investors should start their research on WHSI today: https://topnewsguide.com/wearable-health-solutions-inc-whsi-profile/ This article is part of a sponsored investor education program.
Read more
Wearable Health Solutions, Inc. (OTCMKTS: WHSI) Readies Launch of 4G Product ‘Ecosystem’

Wearable Health Solutions, Inc. (OTCMKTS: WHSI) will launch an ‘ecosystem’ of new products and services to its dealer networks in August. Included are WHSI’s 4G device, docking station and wrist bands, according to Peter Pizzino, president of WHSI, who also noted a “variety of bundled features of the new 4G mobile medical alarm” will be available as well. This is WHSI’s latest innovation in the $30+ billion market of remote Virtual Care and patient monitoring solutions. WHSI’s Catalyst is the 4G iHelp Max Device Key to WHSI’s plans is its debut of the 4G iHelp Max personal care device. WHSI is positioning itself for a leadership position in the new 4G technology in the growing home security and home healthcare markets. Research firm MarketsAndMarkets projects this market will grow at a CAGR of 38.2% to reach $117 billion by 2025. As 3G devices are phased out, WHSI’s new 4G devices offer dealers and vendors next generation iHelp MAX™ 4G features. These include Wi-Fi, NFC (wireless data transfer) technology and Bluetooth 4.0 Low Energy. WHSI Files For Up List, Seeks $5 Million From Capital Markets WHSI is offering investors additional compelling reasons to add the company stock to Watch Lists. WHSI has filed its Form 10 with the SEC for an up list to the OTC: QB market. WHSI’s strategy to become a fully reporting company to the SEC and up list to another trading exchange. The goal: increased visibility to the financial investment community. That also means increased access to the capital markets. WHSI says it plans to raise $5 million in financing in various forms. The funds would be used to expedite the launch of its next generation mobile medical device. This would include its Lone Worker Program initiative. WHSI Retains International Monetary (IM) WHSI has also retained International Monetary (IM), a full service merchant banking and strategic advisory firm. M. B. (Blaine) Riley, III, managing director and president of IM, says, “We will introduce the company to our nationwide brokerage network comprised of broker-dealers and investment banks focused on the micro-cap and small-cap sectors,” he said. “While on the investor relations side, we will direct a series of initiatives to the investment community for enhancing shareholder value and market awareness.” Why It Matters WHSI is investing in R&D, exclusive and proprietary software and a new cloud-based portal for its 4G remote monitoring device.WHSI is offering the robust growth PERS market and its dealer innovation in 4G technology. WHSI is integrating the newest technology, such as voice artificial intelligence (AI), into its existing Smart products. They offer call integration with Alexis and Google, telehealth-ready monitoring wearables plus AI, BlueTooth, IoT, Central Cloud Management, Backend As A Service (Baas) and more. Telehealth Vitals Will Offer Indicators To Medical Professionals WHSI plans to deliver more telehealth features in the future through peripherals such as The iHelp Next Generation Platform (NGP). A biosensor being developed now will feed telehealth vitals into a portal. It will enable medical professionals to see indicators such as temperature, heart rate, pulse, blood pressure (cuffs), glucose monitoring and more. WHSI A Multi-Stream, High Technology Revenue Company WHSI is a multiple revenue stream company. It sells high-technology wearable devices and body mounted sensors internationally. It also operates a subsidiary, Medical Alarm Concepts LLC (MAC), which works with numerous monitoring stations. Keep WHSI stock on your watch list as it integrates technology into its increasingly sophisticated monitoring products. It competes in several dynamic remote monitoring growth markets. For more information, go to wearablehealthsolutions.com This sponsored article is part of an investor education program.
Read more
How ESG Reporting Can Help All Public Companies Improve Investment In Flow

ESG or Environmental, Social and Governance have become increasingly important to investors during the decision-making process. As investor interest has grown in ESG, products and services marketed as such have proliferated, according to Bloomberg Intelligence ESG assets are set to balloon to $50 trillion by 2025 from about $35 trillion.
Read more
How Distribution Could Effect SHNJF Stock

According to Research and Markets, the North American spirits market is expected to reach USD 278.5 billion by 2028, registering a CAGR of 7.7% over the forecast period. Rogue Baron PLC. (OTCMKTS: SHNJF) is one company we’ve been eyeing that has a major opportunity to grab a slice of this rapidly growing market. How SHNJF is Positioned to Accelerate its Revenue Growth Rogue Baron (OTCMKTS: SHNJF) believes if it can reach 10,000 cases sold annually, Shinju will be worth $50 million.SHNJF currently sells 3,000 cases of Shinju Japanese Whiskey annually.7,000 more cases annually would only represent 0.1% of the average annual liquor market growth in the US alone. SHNJF’s Shinju is a high-end liquor with a reasonable price in a fast-growing market, so these projections could be considered conservative.Shinju’s trophy case is impressive: Sante Spirits 2021 Best in Class Sante Spirits 2021 Best WhiskeySante Spirits 2021 Double GoldFifty Best World Whiskey 2021 Silver MedalJohn Barleycorn 2021 Taste Competition Gold Medal WinnerJapanese Whiskey Market Growth in the US is Accelerating:2010 US imports of Japanese whiskey were $1 million 2019 US imports of Japanese whiskey were $50 million Distribution is the Key to SHNJF’s Growth Potential When building a successful liquor brand the key to success is distribution. Distributors help market brands through their network, and if a company is marketing itself, it needs to be sure that retailers carry their product otherwise they lose potential sales. SHNJF has secured European distribution, it delivered its first shipment to the UK market recently. A large catalyst for the stock, however, will be if the stock can complete a deal or two with US/ North American distributors. A few distributors to keep an eye on include: Southern Glazer’s Wine & Spirits- With over 22,500 employees and $21 Billion in annual sales, Southern Glazer is the nation’s largest wine and spirits distributor. The company began in Florida in 1968 and grew quickly through a strategy of acquiring other established distributors. Today Southern operates in 44 states and distributes over 7,000 brands.Breakthru Beverage Corp.- operates in 13 states and the District of Columbia, with sales over $5.6 Billion.Republic National Distributing Company (RNDC)- second largest beverage alcohol distributor of premium wine and spirits in the U.S. with wholly owned operations in Alabama, Colorado, District of Columbia, Florida, Louisiana, Maryland, Mississippi, Nebraska, North Carolina, North Dakota, South Dakota, Texas, Virginia, and West Virginia. RNDC also operates in Arizona, Indiana, Kentucky, Ohio, Oklahoma, and South Carolina through venture partnerships. In total, RNDC employs more than 7,000 hard working individuals nationwide.Empire Merchants North LLC- employs 623 associates and distributes approximately five million cases per year. EMN is the only major locally owned distributorship in upstate New York.Fedway Associates, Inc.- one of the leading distributors in the state of New Jersey. Any deals with one or several of these distributors could catapult SHNJF to a new level. Early investors will benefit. Start your research here: https://topnewsguide.com/japanese-whiskey-offers-early-investors-big-profit-potential/ This article is part of a sponsored investor education program.
Read more
Sparta Commercial (OTCMKTS: SRCO) Share Structure Favorable For Investors

Sparta Commercial Services (OTCMKTS: SRCO) is a financial solutions company and understands fiscal responsibility. As such there are several reasons the share structure alone makes SRCO a potential breakout play. Low-Float- The lower a company’s float is the higher its volatility will be, for investors this means the stock can move easily. While there is not a listed float number on OTCMarkets.com, it does show only ~6.5 million shares are held at DTC. This is less than half of the entire OS. Of the ~15 million total shares outstanding, just over 10 million are unrestricted which is a good indicator of what the actual float is. All an investor has to look at to see how much potential for price appreciation SRCO has is its recent trading history. On February 11th a mere 414 thousand shares almost doubled the company’s share price from $0.09 to $0.16. On March 2nd it took fewer shares (263,448) to double the share price from $0.14 to $0.27. It does not take much for this stock to move, and it is at a favorable position on the chart for entry. Low Risk of Toxic Dilution- The only thing that can ruin a good trading situation is when a company starts issuing shares irresponsibly. Again, this is a financial solutions company with years of market experience, as such, it is tightly held. Even with the ongoing need for capital, SRCO’s management has exhibited its ability to maintain a tight share structure. Its OS is less than 2% of the total authorized, giving the company leverage and flexibility to complete new non-dilutive offerings. Executive Incentive for a Higher Share Price- One source of dilution in the OTC markets is generally executive compensation represented as free trading shares. While a higher share price is generally the goal of any responsible CEO, on the OTC C-level management generally secures their compensation regardless of share price or company performance. SRCO’s executive compensation is calculated via the Black Scholes pricing model. This is the same model utilized to calculate the value of options. As such, SRCO’s C-suite has increased the incentive for a higher valuation. Make sure you are in a position to benefit from the above factors that could send SRCO soaring. SPARTA COMMERCIAL’s STORY The balance sheet and share structure should tell investors all they need to know about SRCO, but there is obviously an underlying story to how its business will continue to grow. How SRCO Makes Money Currently, there are two main verticals driving SRCO’s revenue growth: Vehicle History Reports- The company’s e-commerce technology earns SRCO a large majority of its revenue. Its subsidiary, iMobile Solutions, Inc., through Cyclechex, RVchex, CarVINreport and Truckchex, offer car buyers assurances and are available on Kelly Blue Book, Auto Trader, AllState, and various dealership websites. These reports have been sold in all 50 states and 62 countries.Health and Wellness Products – New World Health Brands, Inc. a CBD and natural dietary supplement brand, is an example of a calculated risk paying off for SRCO. While health and wellness products wouldn’t seem to fit a ‘financial solutions’ model on the surface, New World Health Brands was an opportunity for SRCO to leverage its e-commerce expertise in a fast-growing industry and so far this has proven profitable. Sales have grown by ~80% in the first 9 months of fiscal 2022 vs. the same period in 2021. How SRCO Can Make More Money in 2022 While the above verticals have created revenue growth on their own which should continue, SRCO has several other revenue streams that could start showing up in the balance sheet as soon as the next 10-Q. Municipal Financing Business- The company’s foundation was built on auto-financing. After the 2008 financial crisis, it shifted its focus from consumers to municipalities. When COVID hit, many of these municipalities received grants reducing their need for funding. However, these grants are drying up and SRCO has already announced several new municipal deals, so expect to see this reflected in increased revenue.Mobile App Development- SRCO’s iMobile Solutions subsidiary has signed several app development deals already in 2022, meaning new revenue sources.Crypto-Payment App- SRCO’s crypto-payment app is an exciting solution for merchants looking to accept cryptocurrency payments. This could be a massive revenue stream if it secures adoption. About SRCO’s Crypto Play Sparta Commercial Services’ (OTCMKTS: SRCO) SpartaPayIQ is a crypto payment gateway developed for e-commerce and brick & mortar businesses. SpartaPayIQ will also serve as an integral component of another product (www.SpartaCrypto.com) being developed by SRCO to make the company a vertically integrated crypto commerce company. According to a July 2021 Crypto.com Research Report, there are approximately 221 million cryptocurrency users worldwide holding over $2 Trillion worth of cryptocurrency to spend. That’s why the Global Crypto Payment Gateway Market is expected to grow at a compound annual growth rate (CAGR) of 22.8% over the next six years, according to Brandessence Market Research. SRCO’s UNIQUE FEATURES TO HELP COMPANY GAIN MARKET SHARE Sparta Commercial’s (OTCMKTS: SRCO) crypto payment gateway includes several unique features that will make it desirable for merchants. Zero Cost Merchant Platform- SpartaPayIQ does not charge the merchant any transaction fees for the conversion. Other cryptocurrency payment platforms charge 1% or higher.SpartaPayIQ earns its commission on the exchange rate paid by the buyer so it is able to offer a “zero-cost” platform to the merchants.Eliminates Merchant Conversion Losses- SpartaPayIQ converts payment immediately so the merchant is never actually holding or receiving cryptocurrency. This eliminates the need to manually convert the crypto to fiat, which depending on how long the merchant takes to do the conversion can subject them to market volatility. (Merchants can, however, choose to receive cryptocurrency and convert at their own pace)Eliminates Capital Gains Issues- In many cases, merchants accepting crypto payments and converting are subject to accounting issues such as capital gains tax. SpartaPayIQ’s removes these issues by converting the currency before it touches the merchant. SpartaPayIQ’s ADVANTAGES SRCO’s SpartaPayIQ™ uses contactless, blockchain-based payment processing Read more
Read more
Why WHSI is Perfect for Investors Bullish on Cloud Technology

“It’s inevitable that many of the multibagger stocks of the next decade will be connected to cloud technology in one way or another.” – Lehner Investments The cloud technology industry is one of the fastest growing areas of the technology sector. Cloud Technology’s growth has already made large strides, however, with many industries migrating to the cloud, many research firms expect cloud computing to eclipse $1 trillion annually. One such industry is medical technology and telehealth. Wearable Health Solutions, Inc. (OTCMKTS: WHSI) is a prime example of a company upgrading its technology to meet the needs of its consumers utilizing cloud technology. WHSI’s Next Generation Technology WHSI is set to release its next generation iHelp MAX™ 4G device. The device will do more than transmit an emergency alarm for the user and be able to send medical personnel vital signs, such as heart rate. The next generation is being released as an update on WHSI’s original iHelp™ remote medical alert system, a fully mobile PERS solution that operates anywhere with cellular coverage. The original 3G device offered tracking, geo-fencing, fall detection and extended battery life. It also has voice prompts for safety risk. The upgraded iHelp MAX™ 4G features Wi-Fi, NFC (wireless data transfer) technology and Bluetooth 4.0 Low Energy features. It also offers “telehealth-ready” advantages such as remote monitoring and transmission of the user’s health vitals to emergency personnel and caregivers. WHSI’s iHelp Suite of PERS Devices How WHSI Leverages Cloud Technology to Assist Its Dealers WHSI’s cloud technology helps dealers sell more and ease account management allowing them to retain more subscribers. WHSI’s iHelp Cloud, is a full-service, web-based, account management portal for managing its family of iHelp devices. It is used by iHelp dealers to manage their customers’ devices, cellular networks, monitoring tasks and functionality. The cloud technology helps create a wide range of reports to ensure users have the data needed, when it’s needed. WHSI Cloud Features for Dealers Manage Individual Devices- Dealers can activate, reconfigure, or deactivate a unit. Turn various functions on and off, including geo-fencing, fall detection, GPS location services, medication reminders, circle of care alerts, event history, and much more.Activate/Deactivate Units- Dealers can also activate and/or deactivate units individually or in bulk.Manage Customer Base- The cloud allows dealers to reassign devices to new customers, replace devices, and update customer and contact information.Check Device Status- Remote battery status checks and signal strength of individual devices at any time. Locate a device on demand.Check Airtime Usage- Check airtime usage minutes for the day, week, month, or year.Fulfill Orders Independently- Place orders for more units and/or accessories on your own. Orders are processed and shipped within 24 hours.Access Marketing Materials- Dealers can access a variety of templates, content, and artwork for promotional purposes at no charge. Marketing personnel are available to assist with custom designs if necessary.Access Technical Support- Access to videos and technical support worksheets. Online technical support is also available for one-on-one support. Wearable Health’s effective use of cloud technology is just one reason WHSI is a stock to watch. Click here to learn why investors are starting to place bets on Wearable Health Solutions, Inc. (OTCMKTS: WHSI). This article is part of a sponsored investor education program.
Read more
SHNJF’s Modest Sales Goals Should Be Easy To Reach

Rogue Baron (OTCMKTS: SHNJF) believes if it can reach 10,000 cases sold annually, Shinju will be worth $50 million. SHNJF currently sells 3,000 cases of Shinju Japanese Whiskey annually. 7,000 more cases annually would only represent 0.1% of the average annual liquor market growth in the US alone. SHNJF’s Shinju is a high-end liquor with a reasonable price in a fast-growing market, so these projections could be considered conservative. Japanese whiskey’s popularity has ascended over the past decade. Whiskey exports from Japan are up 233 percent in sales value since 2013, according to a 2020 report from the Foreign Agricultural Service of the United States Department of Agriculture. A couple of round numbers highlighting this growth to consider: 2010 US imports of Japanese whiskey were $1 million 2019 US imports of Japanese whiskey were $50 million Some beverage analysts are forecasting Japan will rival UK, Ireland and Canada as top whiskey exporters. In fact, North America’s top e-commerce alcohol marketplace, Drizly, reports that Japanese Whiskey’s share of the total whiskey category on its marketplace increased 13 percent (from 3.8 percent at this point last year to a 4.3 percent share in 2021). The average unit price of Japanese whisky on Drizly increased to $79.38 in 2021 to date, compared to $74.66 in the same time period in 2020. This leads many to consider Japanese Whiskey as a luxury brand considering the average whiskey unit price on Drizly in 2021 to date was $36.72.According to the Distilled Spirits Council, luxury spirits have grown at an annual rate of 17.7 percent from 2015 to 2020, compared to just 2.5 percent across all spirit brands. The luxury whiskey category, which many Japanese whiskies fall into, has seen an annual growth rate of 11.1 percent in the same time period. That’s why Rogue Baron plc. (OTCMKTS: SHNJF) is so interesting. LUXURY BRAND AT A REASONABLE PRICE Rogue Baron PLC’s Shinju Japanese Whiskey currently retails at $54.99 on Drizly. Well below the average price for Japanese Whiskey, yet a little higher than average. Still, the company’s recent awards signal the taste of a premium brand. Shinju Japanese Whiskey’s 2021 awards include: Sante Spirits 2021 Best in ClassSante Spirits 2021 Best WhiskeySante Spirits 2021 Double GoldFifty Best World Whiskey 2021 Silver MedalJohn Barleycorn 2021 Taste Competition Gold Medal Winner “Shinju Japanese Whisky is double distilled; a well-balanced elegant expression with wafts of honey, orange, and vanilla accompanied by hints of herbaceous notes and light oak. Shinju, meaning “Pearl”, was born from the slopes of the great Mt. Fuji, Japan’s highest and most sacred mountain.” While the product’s great taste is one reason it should easily meet the 10,000 case threshold, the sheer size of the US liquor market shows Americans’ demand for spirits can certainly accommodate SHNJF.GROWTH IN LIQUOR SALES Impact Databank estimates that total U.S. spirits volume reached a new record high of 260 million 9-liter cases in 2021 on a 2% increase. In fact, the spirits market in the U.S. has expanded by more than 42 million cases since 2015, according to Impact Databank. Over that six-year period, the 25 largest spirits brands by volume have added nearly 28 million cases to their total in aggregate, while brands outside the top 25 combined for an increase of 14.7 million cases. Accordingly, the top 25 has increased its volume share of the spirits market to nearly 46%, up from about 42% in 2015. 7,000 more cases annually is not a large number at all, it would only represent 0.1% of the average annual growth in the US alone, and Shinju is positioned globally. Currently, Rogue Baron plc’s portfolio includes Shinju as well as several tequila brands, a champagne brand, and a bar in DC strategically positioned to foster growth in demand in a city filled with tastemakers that travel countrywide. Put SHNJF on your watchlist now. Read more about the Shinju story here. This article is part of a sponsored investor education program.
Read more